Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population.

Autor: Kockerols CCB; Department of Internal Medicine, Albert Schweitzer Hospital. c.c.b.kockerols@asz.nl., Janssen JJWM; Department of Hematology, Amsterdam University Medical Centers, location VUMC., Blijlevens NMA; Department of Hematology, Radboud University Medical Center., Klein SK; Department of Hematology, University Medical Center Groningen., Van Hussen-Daenen LGM; Department of Hematology, University Medical Center Utrecht., Van Gorkom GGY; Department of Hematology, Maastricht University Medical Center., Smit WM; Department of Hematology, Medisch Spectrum Twente., Van Balen P; Department of Hematology, Leiden University Medical Center., Biemond BJ; Department of Hematology, Amsterdam University Medical center, location AMC., Cruijsen MJ; Department of Hematology, Catharina Hospital, Eindhoven., Corsten MF; Department of Hematology, Meander Medical Center, Amersfoort., Te Boekhorst PAW; Department of Hematology, Erasmus University Medical Center, Rotterdam., Koene HR; Department of Hematology, St.-Antonius Hospital, Nieuwegein., Van Sluis GL; Department of Hematology, Isala Hospital, Zwolle., Cornelissen JJ; Department of Hematology, Erasmus University Medical Center, Rotterdam., Westerweel PE; Department of Internal Medicine, Albert Schweitzer Hospital.

Publikováno v: Haematologica [Haematologica] 2023 Jan 01; Vol. 108 (1), pp. 240-244. Date of Electronic Publication: 2023 Jan 01.